These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19895368)

  • 1. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.
    Wang KH; Kao AP; Chang CC; Lee JN; Chai CY; Hou MF; Liu CM; Tsai EM
    Biol Cell; 2010 Jan; 102(3):159-72. PubMed ID: 19895368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines.
    Gadalla SE; Alexandraki A; Lindström MS; Nistér M; Ericsson C
    Biochem Biophys Res Commun; 2011 Feb; 405(4):581-7. PubMed ID: 21266162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing CD44+/CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis.
    Wang KH; Kao AP; Chang CC; Lee JN; Hou MF; Long CY; Chen HS; Tsai EM
    Mol Cancer; 2010 Nov; 9():288. PubMed ID: 21044318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
    Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
    Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of epithelial-mesenchymal transition and tumor growth by 17β-estradiol in an ER(+)/HER2(+) cell line derived from human breast epithelial stem cells.
    Wang KH; Kao AP; Lin TC; Chang CC; Kuo TC
    Biotechnol Appl Biochem; 2012; 59(3):262-7. PubMed ID: 23586837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
    Mosoyan G; Nagi C; Marukian S; Teixeira A; Simonian A; Resnick-Silverman L; DiFeo A; Johnston D; Reynolds SR; Roses DF; Mosoian A
    PLoS One; 2013; 8(1):e55145. PubMed ID: 23372829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
    Oon ML; Thike AA; Tan SY; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):31-41. PubMed ID: 25677743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
    Shao J; Fan W; Ma B; Wu Y
    Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
    Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
    Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: A mathematical approach.
    Turner C; Kohandel M
    J Theor Biol; 2010 Aug; 265(3):329-35. PubMed ID: 20648969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
    Gudadze M; Kankava Q; Mariamidze A; Burkadze G
    Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy.
    Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS
    J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells.
    Deng H; Yin L; Zhang XT; Liu LJ; Wang ML; Wang ZY
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():417-26. PubMed ID: 25158023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
    Weitzenfeld P; Meshel T; Ben-Baruch A
    Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells.
    Vidal LJ; Perry JK; Vouyovitch CM; Pandey V; Brunet-Dunand SE; Mertani HC; Liu DX; Lobie PE
    Mol Cancer Res; 2010 Mar; 8(3):444-56. PubMed ID: 20197384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.